Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Alnylam Pharmaceuticals, Inc. (ALNY) vs Toyota Motor Corp (TM) Price & Performance

Alnylam Pharmaceuticals, Inc.Trade
Toyota Motor CorpTrade

Price performance (Past 24H)

Key statistics

Alnylam Pharmaceuticals, Inc. vs Toyota Motor Corp — how do they compare? Alnylam Pharmaceuticals, Inc. trades at $220.34 (market cap $29.60B), while Toyota Motor Corp trades at $189.04 (market cap $221.79B). The key difference: Toyota Motor Corp is far larger — about 7.5× Alnylam Pharmaceuticals, Inc.'s market cap, and Toyota Motor Corp pays a 3.3% dividend while Alnylam Pharmaceuticals, Inc. pays none. Which is the better fit depends on your goals.

ALNYTM
Market Cap
$29.60B$221.79B
Sector
HealthConsumer Cyclical
52-Week High
$491.22$248.29
52-Week Low
$205.48$166.50
Enterprise Value
$27.56B$414.06B
Dividend Yield
3.3%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.

Read more on ALNY

About Toyota Motor Corp

Founded in 1937, Toyota is one of the world's largest automakers with 10.38 million units sold at retail in fiscal 2022 across its light vehicle brands. Brands include Toyota, Lexus, Daihatsu, and truck maker Hino.

Read more on TM